Australia’s growing tendency to call in the defence force to deal with crises outside its usual remit is cause for concern. Shouldn’t we be better prepared to respond to disasters?
As vaccine eligibility is expanded to adolescents and young adults, understanding who might be more likely to be vaccine hesitant, and why, can help inform public health strategies
Fiona Russell, The University of Melbourne; John Hart, Murdoch Children's Research Institute, and Katherine Gibney, The Peter Doherty Institute for Infection and Immunity
The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.
Offering incentives to encourage good health behavior isn’t new, but it does raise concerns. A behavioral scientist explains how rewarding those taking a shot need not keep ethicists up at night.
The Pfizer COVID-19 vaccine was recently approved for adolescents ages 12-15. Vaccination is essential to protect children from serious illness and quicken return to normal life.
Full population-level protection against COVID-19 will require most adolescents and children to be vaccinated. There are ethical arguments for encouraging vaccination uptake through vaccine mandates.
Public officials are telling us simultaneously to move swiftly on vaccination and also to make thoughtful, reasoned choices about which vaccine we get. These messages are confusing and frustrating.
Canadian public health organizations have run into a serious communication problem about the AstraZeneca vaccine. Crisis management and communication theories explain what’s gone wrong.
From maternity wards to primary care, Canadian researchers are looking to find the positive motivations of vaccine hesitant people, whether they are new parents or other adults.
While Serbia’s Covid-19 infection rate continues to be worrisome, the country has shown the ability to vaccinate a higher proportion of its population than EU nations.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand